Critical appraisal:Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al 2011

From Cancer Guidelines Wiki

Jump to:navigation, search

This appraisal is pending.

Article: Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011 Dec 17;378(9809):2081-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036019.

Assigned to

User:Priyashiel.parikh

Topic area

Guidelines:Colorectal cancer/Primary Prevention

Clinical question

PPR1: What is the risk-benefit ratio for use of aspirin for prevention of colorectal cancer stratified by risk of colorectal cancer itself? (What is the optimal dose and frequency of administration?)

Form: Form:Quality appraisal rct-cochrane
Outcomes: CRC incidence

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment

Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Critical_appraisal:Burn_J,_Gerdes_AM,_Macrae_F,_Mecklin_JP,_Moeslein_G,_Olschwang_S,_et_al_2011&oldid=120615"